Suppr超能文献

氯美噻唑在乙醇戒断模型中的作用。

Action of chlormethiazole in a model of ethanol withdrawal.

作者信息

Green A R, Davies E M, Little H J, Whittington M A, Cross A J

机构信息

Astra Neuroscience Research Unit, London, UK.

出版信息

Psychopharmacology (Berl). 1990;102(2):239-42. doi: 10.1007/BF02245928.

Abstract

Mice withdrawn from exposure for 14 days to ethanol inhalation showed the expected signs of ethanol withdrawal including convulsive behaviour. Injection of chlormethiazole (100 mg/kg) 5 h after the start of withdrawal, at the time that the convulsive behaviour was near maximal, resulted in the virtual disappearance of the withdrawal-induced behaviour within 30 min, with its reappearance by 60 min. A dose of chlormethiazole of 40 mg/kg was without effect. The time course of the effect of chlormethiazole (100 mg/kg) in the withdrawal test was similar to its effect in raising seizure threshold and decreasing locomotor activity. Chlormethiazole did not alter in vitro binding of [3H]-PN 200-110 to the dihydropyridine sensitive Ca2+ channel. Chlormethiazole, a drug used clinically to treat ethanol withdrawal, has therefore been shown to be effective in this animal model of withdrawal. Dihydropyridine calcium antagonists are also active in the model but chlormethiazole is likely to work by a different mechanism and it is suggested that this may be by increasing GABAergic function.

摘要

从吸入乙醇的环境中撤离14天的小鼠表现出了预期的乙醇戒断症状,包括惊厥行为。在戒断开始5小时后,即在惊厥行为接近最大值时,注射氯美噻唑(100毫克/千克),结果在30分钟内戒断诱导的行为几乎消失,60分钟后又重新出现。40毫克/千克的氯美噻唑剂量没有效果。氯美噻唑(100毫克/千克)在戒断试验中的作用时间进程与其提高癫痫阈值和降低运动活性的作用相似。氯美噻唑不会改变[3H]-PN 200-110与二氢吡啶敏感Ca2+通道的体外结合。因此,临床上用于治疗乙醇戒断的药物氯美噻唑已被证明在这种戒断动物模型中是有效的。二氢吡啶类钙拮抗剂在该模型中也有活性,但氯美噻唑可能通过不同的机制起作用,有人认为这可能是通过增强GABA能功能来实现的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验